Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Blank

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
BMC Infectious Diseases|December 12, 2007
Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006Majbrit V Holm, Patricia R Blank, Thomas D Szucs
Journal of Medical Economics|May 29, 2020
Preeclampsia in Switzerland: a cost analysis in two hospitalsMarkus Hodel, Patricia R Blank, Petra Marty, et al.
Vaccine|October 19, 2007
Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006Majbrit V Holm, Patricia R Blank, Thomas D Szucs
BMC Dermatology|June 29, 2010
Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspectivePatricia R Blank, Armin A Blank, Thomas D Szucs
Pharmacoeconomics|June 8, 2010
Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic reviewPatricia R Blank, Konstantin J Dedes, Thomas D Szucs
Journal of Animal Science|November 24, 1999
Effect of fumaric acid and dietary buffering capacity on ileal and fecal amino acid digestibilities in early-weaned pigsR Blank, R Mosenthin, W C Sauer, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
Influenza vaccination coverage rates in Europe--covering five consecutive seasons (2001-2006) in five countriesMajbrit V Holm, Patricia R Blank, Thomas D Szucs
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2011
KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspectivePatricia R Blank, Holger Moch, Thomas D Szucs, et al.
BMC Women'S Health|February 28, 2019
Economic burden of symptomatic iron deficiency - a survey among Swiss womenPatricia R Blank, Yuki Tomonaga, Thomas D Szucs, et al.
Breast Cancer Research and Treatment|April 6, 2010
Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategiesPatricia R Blank, Matthias Schwenkglenks, Holger Moch, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
BMC Infectious Diseases|December 12, 2007
Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006Majbrit V Holm, Patricia R Blank, Thomas D Szucs
Journal of Medical Economics|May 29, 2020
Preeclampsia in Switzerland: a cost analysis in two hospitalsMarkus Hodel, Patricia R Blank, Petra Marty, et al.
Vaccine|October 19, 2007
Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006Majbrit V Holm, Patricia R Blank, Thomas D Szucs
BMC Dermatology|June 29, 2010
Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspectivePatricia R Blank, Armin A Blank, Thomas D Szucs
Pharmacoeconomics|June 8, 2010
Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic reviewPatricia R Blank, Konstantin J Dedes, Thomas D Szucs
Journal of Animal Science|November 24, 1999
Effect of fumaric acid and dietary buffering capacity on ileal and fecal amino acid digestibilities in early-weaned pigsR Blank, R Mosenthin, W C Sauer, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
Influenza vaccination coverage rates in Europe--covering five consecutive seasons (2001-2006) in five countriesMajbrit V Holm, Patricia R Blank, Thomas D Szucs
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2011
KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspectivePatricia R Blank, Holger Moch, Thomas D Szucs, et al.
BMC Women'S Health|February 28, 2019
Economic burden of symptomatic iron deficiency - a survey among Swiss womenPatricia R Blank, Yuki Tomonaga, Thomas D Szucs, et al.
Breast Cancer Research and Treatment|April 6, 2010
Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategiesPatricia R Blank, Matthias Schwenkglenks, Holger Moch, et al.
Pageof 14